Lexicon Pharmaceuticals

+$0.03 (+0.62%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LXRX and other stocks, options, and ETFs commission-free!

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, a treatment for heart failure and type 1 diabetes.

CEO
Lonnel Coats
Employees
78
Headquarters
The Woodlands, Texas
Founded
1995

LXRX Key Statistics

Market Cap
703.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
624.98K
High Today
$4.92
Low Today
$4.73
Open Price
$4.82
Volume
403.98K
52 Week High
$9.65
52 Week Low
$1.03

LXRX Earnings

-$0.77
-$0.27
$0.23
$0.73
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure